Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer

Go back to Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer
(NASDAQ: ERNA) Delayed: 3.99 -0.46 (10.34%)
Previous Close $4.45    52 Week High
Open $4.33    52 Week Low
Day High $4.46    P/E N/A 
Day Low $3.97    EPS
Volume 72,509       

(NASDAQ: ERNA) Delayed: 3.99 -0.46 (10.34%)
Previous Close $4.45    52 Week High
Open $4.33    52 Week Low
Day High $4.46    P/E N/A 
Day Low $3.97    EPS
Volume 72,509